European Commission publishes Omnibus Act VI
On 20 July 2023, the European Commission published the CMR Omnibus VI Regulation (EU) 2023/1490. This regulation prohibits the substances classified as Carcinogenic, Mutagenic and Toxic to Reproduction (CMR) 1A, 1B, or 2 by the 18th Adaptation to Technical Progress (ATP) to the EU Classification Labelling and Packaging (CLP) Regulation. The regulation enters into force on the 1st of December 2023.

On July 20, 2023, the European Commission published Commission Regulation (EU) 2023/1490 (Omnibus Act VI).

This regulation prohibits the use of the CMR (Carcinogenic, Mutagenic or Toxic for Reproduction) substances classified as such in 2022, adding 30 new entries to Annex II to the EU Cosmetics Regulation No. 1223/2009.

WHAT NOW?

Among the 30 new entries, ingredients used in cosmetics which are now classified as CMR (prohibited) are the following:

  • Benzophenone (CAS 119-61-9)
  • Teophylline (CAS 58-55-9)
  • Pentetic Acid (CAS 67-43-6)
  • Pentasodium Pentetate (CAS 140-01-2)
  • Salts of 2-ethylhexanoic acid (Zinc Ethylhexanoate) (CAS 149-57-5)
  • Melamine (CAS 108-78-1)
  • Azadirachta Indica Seed Extract (CAS 84696-25-3)
  • Azadirachta Indica Bark/Seed Extract (CAS 84696-25-3)
  • Trimethylolpropane Triacrylate (CAS 15625-89-5)

The Commission Regulation will apply from 1 December 2023.

Therefore, beauty brands have few months to ensure compliance with the new requirements and to sell the existing stocks. As of December 1, 2023, non-compliant products must be sold or, otherwise, recalled from the EU market.

References:

Commission Regulation (EU) 2023/1490 of 19 July 2023 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use in cosmetic products of certain substances classified as carcinogenic, mutagenic or toxic for reproduction

Linkedin Instagram Facebook

other REGULATORY UPDATES

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »
Any REGULATORY QUESTION?
E-mail

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »

services

CONTACT US

  • info@criticalcatalyst.com
  • +351 91 200 43 51
    PT mobile network call
  • EUROPEAN UNION (HQ)
    679 Avenida da República
    4450-242 Matosinhos (PT)
  • UNITED KINGDOM
    49 Queen Victoria Street
    EC4N 4SA London (UK)